The apolipoprotein L1 gene (APOL1) has been the focus of considerable interest in recent years because of the discovery of two coding genetic variants (G1 and G2) that dramatically increase recessive risk of kidney diseases among African Americans (AAs) [1–3]. This evidence concerns the gene APOL1 and kidney disorder.